Ghrelin, A Novel Placental-Derived Hormone**This work was supported by grants from Xunta de Galicia: PGIDT99PXI20802B, PGIDT99PXI20806B, and Fondo de Investigación Sanitaria, Spanish Ministry of Health, and DGCYT.

Ghrelin, a GH-releasing acylated peptide, has been recently identified from the rat stomach. The purified peptide consists of 28 amino acids in which the serine 3 residue is n-octanoylated. Here we show that ghrelin messenger RNA and ghrelin peptide are present in the human as well as in rat placentae. In human placenta, ghrelin was detected by PCR at both first trimester and after delivery. While ghrelin was not detected by immunohistochemistry in human placenta at term, it was easily identified by immunohistochemistry at first trimester being mainly expressed in cytotrophoblast cells and scarcely in syncytiotrophoblast ones. Ghrelin was also identified in a human choriocarcinoma cell line, the BeWo cells. Ghrelin was found, by immunohistochemistry, in the cytoplasm of labyrinth trophoblast of rat placenta, whereas other placental cell types seems to be negative for ghrelin immunostaining. Moreover, placental ghrelin messenger RNA, in pregnant rats, showed a characteristic profile of expression being practically undetectable during early pregnancy, with a sharp peak of expression at day 16 and decreasing in the latest stages of gestation. In conclusion, ghrelin has been detected in human and rat placenta showing a pregnancy-related time course of expression. Whether placenta-derived ghrelin is involved in the modulation of GH release, or placental cell growth and differentiation remains to be established.

[1]  K. Kangawa,et al.  Purification and Characterization of Rat des-Gln14-Ghrelin, a Second Endogenous Ligand for the Growth Hormone Secretagogue Receptor* , 2000, The Journal of Biological Chemistry.

[2]  F. Casanueva,et al.  Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulation. , 2000, European journal of endocrinology.

[3]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[4]  F. Casanueva,et al.  Prolactin Stimulates Leptin Secretion by Rat White Adipose Tissue1. , 1999, Endocrinology.

[5]  F. Casanueva,et al.  Growth Hormone Secretagogues: Physiological Role and Clinical Utility , 1999, Trends in Endocrinology & Metabolism.

[6]  F. Casanueva,et al.  Synthesis of Leptin in Human Placenta. , 1997, Endocrinology.

[7]  M. Paul,et al.  Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. , 1997, BioTechniques.

[8]  M. Phillips,et al.  Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. , 1997, Molecular endocrinology.

[9]  Patrick R. Griffin,et al.  A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release , 1996, Science.

[10]  C. Nappi,et al.  Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. , 1996, Endocrine reviews.

[11]  L. Shaffer,et al.  Duplication 3q syndrome: molecular delineation of the critical region. , 1995, American journal of medical genetics.

[12]  C. Bondy,et al.  Insulin-like growth factor-II and its binding proteins in placental development. , 1992, Endocrinology.

[13]  O. Pescovitz,et al.  Growth hormone-releasing hormone-like messenger ribonucleic acid and immunoreactive peptide are present in human testis and placenta. , 1992, The Journal of clinical endocrinology and metabolism.

[14]  J. van Beeumen,et al.  Identification of placental human growth hormone as the growth hormone-V gene expression product. , 1990, The Journal of clinical endocrinology and metabolism.

[15]  F. Wondisford,et al.  Isolation and characterization of the human gonadotropin-releasing hormone gene in the hypothalamus and placenta. , 1990, Molecular endocrinology.

[16]  S. Suhr,et al.  Mouse growth-hormone-releasing hormone: precursor structure and expression in brain and placenta. , 1989, Molecular endocrinology.

[17]  M. Daimon,et al.  Insulin-like growth factor-I messenger ribonucleic acid in the developing human placenta and in term placenta of diabetics. , 1988, Molecular endocrinology.

[18]  P. Sawchenko,et al.  Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta , 1987, Nature.

[19]  H. Munro,et al.  An autocrine/paracrine role for insulin-like growth factors in the regulation of human placental growth. , 1986, The Journal of clinical endocrinology and metabolism.

[20]  W. B. Watkins,et al.  Somatostatin in cytotrophoblast of the immature human placenta: localization by immunoperoxidase cytochemistry. , 1980, The Journal of clinical endocrinology and metabolism.

[21]  S. Yagihashi,et al.  Immunohistochemical demonstration of somatostatin-containing cells in the human placenta. , 1978, The Tohoku journal of experimental medicine.

[22]  F. Casanueva,et al.  Chapter 17 – Growth Hormone Secretagogues. Physiological Role and Clinical Implications , 1999 .

[23]  P. Gluckman,et al.  The physiology and pathophysiology of intrauterine growth retardation. , 1997, Hormone research.

[24]  N. Vamvakopoulos,et al.  Expression and localization of growth hormone-releasing hormone messenger ribonucleic acid in rat placenta: in vitro secretion and regulation of its peptide product. , 1990, Endocrinology.